Evolution of the Average Target: Amarin Corporation plc

Evolution of the Target Price: Amarin Corporation plc

Changes in Analyst Recommendations: Amarin Corporation plc

7873fea.RitqAIi_9xZFW3aK88Ro9DYvfOyw3yrO_MzPnenMcks.MWQnMcfNjU4aBCHPgLAfoV9sL5mA51KjtbaF2YuvGy0fcg9EpfiRWB0WNw~8c0357c2f7b7791dcc6790e483a09640
27/10/25 Amarin issues statement supporting FDA's action to revise labeling for fenofibrate drugs reinforcing a lack of cardiovascular benefit RE
25/06/25 RBC Ups Recordati's Price Target on Cardiovascular Drug European Licensing Deal MT
25/10/23 Jefferies Downgrades Amarin to Hold From Buy, Cuts Price Target to $1 From $3 MT
19/07/23 Northland Adjusts Price Target on Amarin to $1.25 From $2, Maintains Market Perform Rating MT
06/01/23 Jefferies Upgrades Amarin to Buy From Hold, Adjusts Price Target to $3 From $1.30 MT
19/10/22 SVB Securities Adjusts Amarin's Price Target to $2 From $3, Maintains Market Perform Rating MT
06/05/22 JPMorgan Downgrades Amarin to Underweight From Neutral MT
05/05/22 HC Wainwright Lowers Amarin to Neutral From Buy, Price Target to $3 From $10 MT
05/05/22 SVB Leerink Downgrades Amarin to Market Perform From Outperform, Adjusts Price Target to $3 From $10 MT
05/05/22 Northland Downgrades Amarin to Market Perform From Outperform, Adjusts Price Target to $2 From $9 MT
16/02/22 SVB Leerink Adjusts Amarin's Price Target to $10 from $11, Maintains Outperform Rating MT
31/01/22 SVB Leerink Adjusts Amarin's Price Target to $11 from $12, Keeps Outperform Rating MT
12/05/21 AMARIN : Goldman Sachs Downgrades Amarin to Sell From Neutral, Adjusts Price Target to $5 From $6 MT
01/02/21 AMARIN : SVB Leerink Adjusts Price Target on Amarin to $16 From $12, Maintains Outperform Rating MT
23/12/20 AMARIN : Goldman Sachs Adjusts Amarin's Price Target to $6 From $8, Maintains Neutral Rating MT
07/12/20 AMARIN : Citigroup Adjusts Amarin's Price Target to $7 from $12, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- -22.02%
+9.72%
+42.1%
+36.27%
+105.79%
+51.99%
+41.35%
-5.61%
-23.54%
+31.71%
Average +26.78%
Weighted average by Cap. +32.60%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
16.03USD
Average target price
12.50USD
Spread / Average Target
-22.02%
High Price Target
13.00USD
Spread / Highest target
-18.90%
Low Price Target
12.00USD
Spread / Lowest Target
-25.14%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Jefferies & Co.
Northland Securities
SVB Securities LLC
JPMorgan Chase
SVB Leerink
HC Wainwright
Goldman Sachs
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
16.03USD
Average target price
12.50USD
Spread / Average Target
-22.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRN Stock
  4. Consensus Amarin Corporation plc
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!